Mike Nally is currently Chief Marketing Officer, MSD, a global healthcare company with a 125-year history discovering, developing and providing innovative products and services that save and improve lives around the world. In this role Mike is responsible for Global Marketing and Brand Strategy across a vast portfolio, exceeding $40B in revenue, of innovative medicines and vaccines.
Prior to this role, Mike served as President of Global Vaccines at MSD, providing a broad portfolio of pediatric, adolescent, and adult vaccines to the world. In this position, Mike and his team worked to drive a dramatic increase in the reach and public health impact of vaccines, while delivering significant business growth.
Additionally, Mike has led the company's business in Sweden and the UK, focusing on the development and implementation of innovative, customer-centered approaches that delivered improved business results and accelerated patient access to our medicines. He has also held a variety of positions in Commercial Operations, Business Development and Investor Relations.
Mike holds an MBA from Harvard Business School, a degree in Accounting and Finance from the London School of Economics and a BA in Economics from Middlebury College.
